{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T06:17:02Z","timestamp":1795241822078,"version":"4.10.3"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22173118"],"award-info":[{"award-number":["22173118"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-62288-7","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T17:27:40Z","timestamp":1755883660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Harnessing artificial intelligence to identify Bufalin as a molecular glue degrader of estrogen receptor alpha"],"prefix":"10.1038","volume":"16","author":[{"given":"Shilong","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2188-0110","authenticated-orcid":false,"given":"Keyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changxin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonglin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7905-0443","authenticated-orcid":false,"given":"Yan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3604-3785","authenticated-orcid":false,"given":"Dongsheng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"62288_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04613-6","volume":"21","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt\/\u03b2-catenin signal pathway. J. Transl. Med. 21, 900 (2023).","journal-title":"J. Transl. Med."},{"key":"62288_CR2","doi-asserted-by":"publisher","first-page":"e004297","DOI":"10.1136\/jitc-2021-004297","volume":"10","author":"Z Yu","year":"2022","unstructured":"Yu, Z. et al. Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma. J. Immunother. Cancer 10, e004297 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"62288_CR3","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.3390\/molecules28052231","volume":"28","author":"AA Farooqi","year":"2023","unstructured":"Farooqi, A. A. et al. Bufalin-mediated regulation of cell signaling pathways in different cancers: spotlight on JAK\/STAT, Wnt\/\u03b2-Catenin, mTOR, TRAIL\/TRAIL-R, and non-coding RNAs. Molecules 28, 2231 (2023).","journal-title":"Molecules"},{"key":"62288_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2021.05.008","volume":"513","author":"J Chen","year":"2021","unstructured":"Chen, J. et al. Bufalin targets the SRC-3\/MIF pathway in chemoresistant cells to regulate M2 macrophage polarization in colorectal cancer. Cancer Lett. 513, 63\u201374 (2021).","journal-title":"Cancer Lett."},{"key":"62288_CR5","doi-asserted-by":"publisher","first-page":"106442","DOI":"10.1016\/j.phrs.2022.106442","volume":"184","author":"L Soumoy","year":"2022","unstructured":"Soumoy, L., Ghanem, G. E., Saussez, S. & Journe, F. Bufalin for an innovative therapeutic approach against cancer. Pharm. Res. 184, 106442 (2022).","journal-title":"Pharm. Res."},{"key":"62288_CR6","doi-asserted-by":"publisher","first-page":"110746","DOI":"10.1016\/j.cellsig.2023.110746","volume":"109","author":"Z Qian","year":"2023","unstructured":"Qian, Z. et al. Bufalin inhibits the proliferation of lung cancer cells by suppressing Hippo-YAP pathway. Cell Signal 109, 110746 (2023).","journal-title":"Cell Signal"},{"key":"62288_CR7","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1007\/s10495-023-01855-z","volume":"28","author":"G Chen","year":"2023","unstructured":"Chen, G. et al. Bufalin targeting BFAR inhibits the occurrence and metastasis of gastric cancer through PI3K\/AKT\/mTOR signal pathway. Apoptosis 28, 1390\u20131405 (2023).","journal-title":"Apoptosis"},{"key":"62288_CR8","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1158\/0008-5472.CAN-13-2939","volume":"74","author":"Y Wang","year":"2014","unstructured":"Wang, Y. et al. Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1. Cancer Res. 74, 1506\u20131517 (2014).","journal-title":"Cancer Res."},{"key":"62288_CR9","doi-asserted-by":"publisher","first-page":"102776","DOI":"10.1016\/j.sbi.2024.102776","volume":"85","author":"Y Qiu","year":"2024","unstructured":"Qiu, Y. & Cheng, F. Artificial intelligence for drug discovery and development in Alzheimer\u2019s disease. Curr. Opin. Struct. Biol. 85, 102776 (2024).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"62288_CR10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.tips.2023.06.010","volume":"44","author":"FW Pun","year":"2023","unstructured":"Pun, F. W., Ozerov, I. V. & Zhavoronkov, A. AI-powered therapeutic target discovery. Trends Pharm. Sci. 44, 561\u2013572 (2023).","journal-title":"Trends Pharm. Sci."},{"key":"62288_CR11","doi-asserted-by":"publisher","first-page":"112644","DOI":"10.1016\/j.ejmech.2020.112644","volume":"204","author":"H Wei","year":"2020","unstructured":"Wei, H. et al. A combinatorial target screening strategy for deorphaning macromolecular targets of natural product. Eur. J. Med. Chem. 204, 112644 (2020).","journal-title":"Eur. J. Med. Chem."},{"key":"62288_CR12","doi-asserted-by":"publisher","first-page":"112421","DOI":"10.1016\/j.ejmech.2020.112421","volume":"199","author":"DS Cao","year":"2020","unstructured":"Cao, D. S. et al. A multi-scale systems pharmacology approach uncovers the anti-cancer molecular mechanism of Ixabepilone. Eur. J. Med. Chem. 199, 112421 (2020).","journal-title":"Eur. J. Med. Chem."},{"key":"62288_CR13","doi-asserted-by":"crossref","unstructured":"Wei, X. et al. Predicting novel targets with Bayesian machine learning by integrating multiple biological signatures. Chem. Sci. 15, 14471\u201314484 (2024).","DOI":"10.1039\/D4SC03580A"},{"key":"62288_CR14","doi-asserted-by":"publisher","first-page":"11094","DOI":"10.1021\/acs.jmedchem.3c00465","volume":"66","author":"X Deng","year":"2023","unstructured":"Deng, X. et al. Identification of Novel Dual-Target Estrogen Receptor \u03b1 Degraders with Tubulin inhibitory activity for the treatment of endocrine-resistant breast cancer. J. Med Chem. 66, 11094\u201311117 (2023).","journal-title":"J. Med Chem."},{"key":"62288_CR15","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/cbin.12123","volume":"48","author":"W Zhao","year":"2024","unstructured":"Zhao, W. et al. Ginsenoside Rg3 overcomes tamoxifen resistance through inhibiting glycolysis in breast cancer cells. Cell Biol. Int. 48, 496\u2013509 (2024).","journal-title":"Cell Biol. Int."},{"key":"62288_CR16","doi-asserted-by":"publisher","first-page":"e2940","DOI":"10.1002\/iub.2940","volume":"77","author":"J Yuan","year":"2025","unstructured":"Yuan, J. et al. Tinagl1 restores tamoxifen sensitivity and blocks fibronectin-induced EMT by simultaneously blocking the EGFR and \u03b21-integrin\/FAK signaling pathways in tamoxifen-resistant breast cancer cells. IUBMB Life 77, e2940 (2025).","journal-title":"IUBMB Life"},{"key":"62288_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s11030-020-10133-y","volume":"25","author":"N Kumar","year":"2021","unstructured":"Kumar, N. et al. Most recent strategies targeting estrogen receptor alpha for the treatment of breast cancer. Mol. Divers 25, 603\u2013624 (2021).","journal-title":"Mol. Divers"},{"key":"62288_CR18","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1056\/NEJMc2101282","volume":"384","author":"HJ Burstein","year":"2021","unstructured":"Burstein, H. J. Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer reply. Reply, N. Engl. J. Med. 384, 1176\u20131177 (2021).","journal-title":"Reply, N. Engl. J. Med."},{"key":"62288_CR19","doi-asserted-by":"publisher","first-page":"117235","DOI":"10.1016\/j.bmc.2023.117235","volume":"82","author":"J Zhou","year":"2023","unstructured":"Zhou, J. et al. A novel selective estrogen receptor degrader induces cell cycle arrest in breast cancer via ER\u03b1 degradation and the autophagy-lysosome pathway. Bioorg. Med. Chem. 82, 117235 (2023).","journal-title":"Bioorg. Med. Chem."},{"key":"62288_CR20","doi-asserted-by":"publisher","first-page":"10230","DOI":"10.1093\/nar\/gkac778","volume":"50","author":"ZZ Zheng","year":"2022","unstructured":"Zheng, Z. Z. et al. Super-enhancer-controlled positive feedback loop BRD4\/ER\u03b1-RET-ER\u03b1 promotes ER\u03b1-positive breast cancer. Nucleic Acids Res. 50, 10230\u201310248 (2022).","journal-title":"Nucleic Acids Res."},{"key":"62288_CR21","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.7150\/thno.39814","volume":"10","author":"XS Chen","year":"2020","unstructured":"Chen, X. S. et al. UCH-L1-mediated Down-regulation of Estrogen Receptor \u03b1 Contributes to Insensitivity to Endocrine Therapy for Breast Cancer. Theranostics 10, 1833\u20131848 (2020).","journal-title":"Theranostics"},{"key":"62288_CR22","doi-asserted-by":"publisher","first-page":"e2300560","DOI":"10.1002\/biot.202300560","volume":"19","author":"S Liu","year":"2024","unstructured":"Liu, S. et al. MCM2 is involved in subtyping and tamoxifen resistance of ER\u03b1-positive breast cancer by acting as the downstream factor of ER\u03b1,. Biotechnol. J. 19, e2300560 (2024).","journal-title":"Biotechnol. J."},{"key":"62288_CR23","doi-asserted-by":"crossref","unstructured":"Lai, X. et al., HGF\/c-Met Promotes Breast Cancer Tamoxifen Resistance Through the EZH2\/HOTAIR-miR-141\/200a Feedback Signaling Pathway. Mol. Carcinog. 64, 769\u2013783 (2025).","DOI":"10.1002\/mc.23878"},{"key":"62288_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07423-4","volume":"16","author":"V Melone","year":"2025","unstructured":"Melone, V. et al. LncRNA PVT1 links estrogen receptor alpha and the polycomb repressive complex 2 in suppression of pro-apoptotic genes in hormone-responsive breast cancer. Cell Death Dis. 16, 80 (2025).","journal-title":"Cell Death Dis."},{"key":"62288_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1021\/acs.jcim.3c01250","volume":"64","author":"E Heid","year":"2024","unstructured":"Heid, E. et al. Chemprop: A Machine Learning Package for Chemical Property Prediction. J. Chem. Inf. Model 64, 9\u201317 (2024).","journal-title":"J. Chem. Inf. Model"},{"key":"62288_CR26","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/bcpt.13487","volume":"128","author":"S Su","year":"2021","unstructured":"Su, S., Dou, H., Wang, Z. & Zhang, Q. Bufalin inhibits ovarian carcinoma via targeting mTOR\/HIF-\u03b1 pathway. Basic Clin. Pharm. Toxicol. 128, 224\u2013233 (2021).","journal-title":"Basic Clin. Pharm. Toxicol."},{"key":"62288_CR27","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s13402-020-00546-0","volume":"43","author":"Z Yu","year":"2020","unstructured":"Yu, Z. et al. Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation. Cell Oncol. 43, 1129\u20131145 (2020).","journal-title":"Cell Oncol."},{"key":"62288_CR28","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.4049\/jimmunol.1400806","volume":"194","author":"RY Chen","year":"2015","unstructured":"Chen, R. Y. et al. Estradiol inhibits Th17 cell differentiation through inhibition of ROR\u03b3T transcription by recruiting the ER\u03b1\/REA complex to estrogen response elements of the ROR\u03b3T promoter. J. Immunol. 194, 4019\u20134028 (2015).","journal-title":"J. Immunol."},{"key":"62288_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.mce.2015.08.007","volume":"415","author":"AJ Casa","year":"2015","unstructured":"Casa, A. J., Hochbaum, D., Sreekumar, S., Oesterreich, S. & Lee, A. V. The estrogen receptor alpha nuclear localization sequence is critical for fulvestrant-induced degradation of the receptor. Mol. Cell Endocrinol. 415, 76\u201386 (2015).","journal-title":"Mol. Cell Endocrinol."},{"key":"62288_CR30","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s13577-022-00810-5","volume":"36","author":"L Yuan","year":"2023","unstructured":"Yuan, L., Li, X., Yang, H. & Li, H. The ubiquitin ligase RNF2 stabilizes ER\u03b1 and modulates breast cancer progression. Hum. Cell 36, 353\u2013365 (2023).","journal-title":"Hum. Cell"},{"key":"62288_CR31","doi-asserted-by":"publisher","first-page":"6776","DOI":"10.1038\/s41388-020-01464-z","volume":"39","author":"J Zhu","year":"2020","unstructured":"Zhu, J. et al. The ubiquitin ligase RNF181 stabilizes ER\u03b1 and modulates breast cancer progression. Oncogene 39, 6776\u20136788 (2020).","journal-title":"Oncogene"},{"key":"62288_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-019-0139-x","volume":"8","author":"M Xue","year":"2019","unstructured":"Xue, M. et al. Regulation of estrogen signaling and breast cancer proliferation by an ubiquitin ligase TRIM56. Oncogenesis 8, 30 (2019).","journal-title":"Oncogenesis"},{"key":"62288_CR33","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1210\/me.2005-0111","volume":"19","author":"M Fan","year":"2005","unstructured":"Fan, M., Park, A. & Nephew, K. P. CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha. Mol. Endocrinol. 19, 2901\u20132914 (2005).","journal-title":"Mol. Endocrinol."},{"key":"62288_CR34","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1379\/1466-1268(2003)008<0303:CALBTC>2.0.CO;2","volume":"8","author":"H McDonough","year":"2003","unstructured":"McDonough, H. & Patterson, C. CHIP: a link between the chaperone and proteasome systems. Cell Stress Chaperones 8, 303\u2013308 (2003).","journal-title":"Cell Stress Chaperones"},{"key":"62288_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01515-y","volume":"22","author":"H Luo","year":"2024","unstructured":"Luo, H., Liu, N. & Lin, C. Dopamine enhances recovery after traumatic brain injury through ubiquitylation and autophagic degradation of RIPK1. Cell Commun. Signal 22, 134 (2024).","journal-title":"Cell Commun. Signal"},{"key":"62288_CR36","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1158\/1535-7163.MCT-20-0390","volume":"20","author":"M Shomali","year":"2021","unstructured":"Shomali, M. et al. SAR439859, a Novel Selective Estrogen Receptor Degrader (SERD), demonstrates effective and broad antitumor activity in wild-type and mutant ER-Positive breast cancer models. Mol. Cancer Ther. 20, 250\u2013262 (2021).","journal-title":"Mol. Cancer Ther."},{"key":"62288_CR37","doi-asserted-by":"publisher","first-page":"1274336","DOI":"10.3389\/fphar.2023.1274336","volume":"14","author":"Q Ye","year":"2023","unstructured":"Ye, Q. et al. An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives. Front. Pharm. 14, 1274336 (2023).","journal-title":"Front. Pharm."},{"key":"62288_CR38","doi-asserted-by":"publisher","first-page":"i539","DOI":"10.1093\/bioinformatics\/btae240","volume":"40","author":"Z Zhang","year":"2024","unstructured":"Zhang, Z., He, X., Long, D., Luo, G. & Chen, S. Enhancing generalizability and performance in drug-target interaction identification by integrating pharmacophore and pre-trained models. Bioinformatics 40, i539\u2013i547 (2024).","journal-title":"Bioinformatics"},{"key":"62288_CR39","doi-asserted-by":"publisher","first-page":"btae346","DOI":"10.1093\/bioinformatics\/btae346","volume":"40","author":"W Song","year":"2024","unstructured":"Song, W., Xu, L., Han, C., Tian, Z. & Zou, Q. Drug-target interaction predictions with multi-view similarity network fusion strategy and deep interactive attention mechanism. Bioinformatics 40, btae346 (2024).","journal-title":"Bioinformatics"},{"key":"62288_CR40","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3390\/molecules25061375","volume":"25","author":"X Lin","year":"2020","unstructured":"Lin, X., Li, X. & Lin, X. A Review on Applications of Computational Methods in Drug Screening and Design. Molecules 25, 1375 (2020).","journal-title":"Molecules"},{"key":"62288_CR41","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s41401-018-0165-9","volume":"40","author":"SL Jiang","year":"2019","unstructured":"Jiang, S. L. et al. Tubeimoside-1, a triterpenoid saponin, induces cytoprotective autophagy in human breast cancer cells in vitro via Akt-mediated pathway. Acta Pharm. Sin. 40, 919\u2013928 (2019).","journal-title":"Acta Pharm. Sin."},{"key":"62288_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03153-x","volume":"11","author":"Y Guan","year":"2020","unstructured":"Guan, Y. et al. Combined treatment of mitoxantrone sensitizes breast cancer cells to rapalogs through blocking eEF-2K-mediated activation of Akt and autophagy. Cell Death Dis. 11, 948 (2020).","journal-title":"Cell Death Dis."},{"key":"62288_CR43","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.1007\/s13277-015-4381-3","volume":"37","author":"T Wang","year":"2016","unstructured":"Wang, T. et al. The effects of bufadienolides on HER2 overexpressing breast cancer cells. Tumour Biol. 37, 7155\u20137163 (2016).","journal-title":"Tumour Biol."},{"key":"62288_CR44","doi-asserted-by":"publisher","first-page":"156130","DOI":"10.1016\/j.phymed.2024.156130","volume":"135","author":"S Wu","year":"2024","unstructured":"Wu, S. et al. Bufalin induces ferroptosis by modulating the 2,4-dienoyl-CoA reductase (DECR1)-SLC7A11 axis in breast cancer. Phytomedicine 135, 156130 (2024).","journal-title":"Phytomedicine"},{"key":"62288_CR45","doi-asserted-by":"crossref","unstructured":"Li, C. et al. Bufalin Ameliorates Myocardial Ischemia\/Reperfusion Injury by Suppressing Macrophage Pyroptosis via P62 Pathway. J. Cardiovasc. Transl. Res. 18, 221\u2013236 (2024).","DOI":"10.1007\/s12265-024-10577-9"},{"key":"62288_CR46","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1002\/cbin.12021","volume":"47","author":"YD Zheng","year":"2023","unstructured":"Zheng, Y. D. et al. Bufalin induces apoptosis and autophagy via the Ca2+\/CaMKK\u03b2\/AMPK\/Beclin1 signaling pathway in osteosarcoma cells. Cell Biol. Int. 47, 1344\u20131353 (2023).","journal-title":"Cell Biol. Int."},{"key":"62288_CR47","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1007\/s11655-021-3458-7","volume":"28","author":"XD Liu","year":"2022","unstructured":"Liu, X. D., Song, C. Y., Kong, C. C. & Tian, X. Bufalin Induces Programmed Necroptosis in Triple-Negative Breast Cancer Drug-Resistant Cell Lines through RIP1\/ROS-Mediated Pathway. Chin. J. Integr. Med. 28, 900\u2013908 (2022).","journal-title":"Chin. J. Integr. Med."},{"key":"62288_CR48","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1158\/1535-7163.MCT-17-1296","volume":"17","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. Role of P53-Senescence induction in suppression of LNCaP prostate cancer growth by cardiotonic compound bufalin. Mol. Cancer Ther. 17, 2341\u20132352 (2018).","journal-title":"Mol. Cancer Ther."},{"key":"62288_CR49","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1159\/000485279","volume":"44","author":"T Liu","year":"2017","unstructured":"Liu, T. et al. Bufalin inhibits cellular proliferation and cancer stem cell-like phenotypes via upregulation of MiR-203 in Glioma. Cell Physiol. Biochem. 44, 671\u2013681 (2017).","journal-title":"Cell Physiol. Biochem."},{"key":"62288_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.839005","volume":"13","author":"P Chen","year":"2022","unstructured":"Chen, P., Li, B. & Ou-Yang, L. Role of estrogen receptors in health and disease. Front Endocrinol.13, 839005 (2022).","journal-title":"Front Endocrinol."},{"key":"62288_CR51","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.semcancer.2016.03.001","volume":"40-41","author":"MJ Bak","year":"2016","unstructured":"Bak, M. J., Das Gupta, S., Wahler, J. & Suh, N. Role of dietary bioactive natural products in estrogen receptor-positive breast cancer. Semin Cancer Biol. 40-41, 170\u2013191 (2016).","journal-title":"Semin Cancer Biol."},{"key":"62288_CR52","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.1016\/j.apsb.2023.05.005","volume":"13","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancer. Acta Pharm. Sin. B. 13, 4963\u20134982 (2023).","journal-title":"Acta Pharm. Sin. B."},{"key":"62288_CR53","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","volume":"21","author":"M B\u00e9k\u00e9s","year":"2022","unstructured":"B\u00e9k\u00e9s, M., Langley, D. R. & Crews, C. M. PROTAC targeted protein degraders: the past is prologue. Nat. Rev. Drug Discov. 21, 181\u2013200 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"62288_CR54","doi-asserted-by":"crossref","unstructured":"Lemaitre, T. et al. Molecular glue degraders: exciting opportunities for novel drug discovery. Expert Opin. Drug Discov. 19, 433\u2013449 (2024).","DOI":"10.1080\/17460441.2024.2306845"},{"key":"62288_CR55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cell.2020.12.020","volume":"184","author":"SL Schreiber","year":"2021","unstructured":"Schreiber, S. L. The Rise of Molecular Glues. Cell 184, 3\u20139 (2021).","journal-title":"Cell"},{"key":"62288_CR56","doi-asserted-by":"publisher","first-page":"104353","DOI":"10.1016\/j.ebiom.2022.104353","volume":"86","author":"TT Liu","year":"2022","unstructured":"Liu, T. T. et al. Atypical E3 ligase ZFP91 promotes small-molecule-induced E2F2 transcription factor degradation for cancer therapy. EBioMedicine 86, 104353 (2022).","journal-title":"EBioMedicine"},{"key":"62288_CR57","doi-asserted-by":"publisher","first-page":"13738","DOI":"10.18632\/aging.205260","volume":"15","author":"J Zhu","year":"2023","unstructured":"Zhu, J. et al. Involvement of RFC3 in tamoxifen resistance in ER-positive breast cancer through the cell cycle. Aging 15, 13738\u201313752 (2023).","journal-title":"Aging"},{"key":"62288_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-024-01790-0","volume":"26","author":"T Song","year":"2024","unstructured":"Song, T. et al. Small molecule inhibitor targeting the Hsp70-Bim protein-protein interaction in estrogen receptor-positive breast cancer overcomes tamoxifen resistance. Breast Cancer Res. 26, 33 (2024).","journal-title":"Breast Cancer Res."},{"key":"62288_CR59","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ccell.2020.03.009","volume":"37","author":"AB Hanker","year":"2020","unstructured":"Hanker, A. B., Sudhan, D. R. & Arteaga, C. L. Overcoming endocrine resistance in breast cancer. Cancer Cell 37, 496\u2013513 (2020).","journal-title":"Cancer Cell"},{"key":"62288_CR60","doi-asserted-by":"publisher","first-page":"15094","DOI":"10.1021\/acs.jmedchem.0c00913","volume":"63","author":"Y Lu","year":"2020","unstructured":"Lu, Y. & Liu, W. Selective Estrogen Receptor Degraders (SERDs): A promising strategy for estrogen receptor positive endocrine-resistant breast cancer. J. Med Chem. 63, 15094\u201315114 (2020).","journal-title":"J. Med Chem."},{"key":"62288_CR61","doi-asserted-by":"publisher","first-page":"6631","DOI":"10.1021\/acs.jmedchem.2c02032","volume":"66","author":"B Xie","year":"2023","unstructured":"Xie, B. et al. Discovery of a novel class of PROTACs as potent and selective estrogen receptor \u03b1 degraders to overcome endocrine-resistant breast cancer in vitro and in vivo. J. Med Chem. 66, 6631\u20136651 (2023).","journal-title":"J. Med Chem."},{"key":"62288_CR62","doi-asserted-by":"publisher","first-page":"7993","DOI":"10.1021\/acs.jmedchem.2c00525","volume":"65","author":"X Deng","year":"2022","unstructured":"Deng, X. et al. Discovery of novel bicyclic phenylselenyl-containing hybrids: an orally bioavailable, potential, and multiacting class of estrogen receptor modulators against endocrine-resistant breast cancer. J. Med Chem. 65, 7993\u20138010 (2022).","journal-title":"J. Med Chem."},{"key":"62288_CR63","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S0092-8674(00)81717-1","volume":"95","author":"AK Shiau","year":"1998","unstructured":"Shiau, A. K. et al. The structural basis of estrogen receptor\/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95, 927\u2013937 (1998).","journal-title":"Cell"},{"key":"62288_CR64","doi-asserted-by":"publisher","first-page":"e0130433","DOI":"10.1371\/journal.pone.0130433","volume":"10","author":"S \u00d3 Conch\u00fair","year":"2015","unstructured":"\u00d3 Conch\u00fair, S. et al. A web resource for standardized benchmark datasets, metrics, and rosetta protocols for macromolecular modeling and design. PLoS One. 10, e0130433 (2015).","journal-title":"PLoS One."},{"key":"62288_CR65","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/978-1-0716-0708-4_9","volume":"2165","author":"A Alekseenko","year":"2020","unstructured":"Alekseenko, A., Ignatov, M., Jones, G., Sabitova, M. & Kozakov, D. Protein-protein and protein-peptide docking with ClusPro server. Methods Mol. Biol. 2165, 157\u2013174 (2020).","journal-title":"Methods Mol. Biol."},{"key":"62288_CR66","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","volume":"16","author":"C Tian","year":"2020","unstructured":"Tian, C. et al. ff19SB: Amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution. J. Chem. Theory Comput. 16, 528\u2013552 (2020).","journal-title":"J. Chem. Theory Comput."},{"key":"62288_CR67","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A. & Case, D. A. Development and testing of a general amber force field. J. Comput Chem. 25, 1157\u20131174 (2004).","journal-title":"J. Comput Chem."},{"key":"62288_CR68","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1021\/acs.jcim.3c01153","volume":"63","author":"DA Case","year":"2023","unstructured":"Case, D. A. et al. AmberTools. J. Chem. Inf. Model 63, 6183\u20136191 (2023).","journal-title":"J. Chem. Inf. Model"},{"key":"62288_CR69","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/ct300418h","volume":"8","author":"BR Miller 3rd","year":"2012","unstructured":"Miller, B. R. 3rd et al. MMPBSA.py: An Efficient Program for End-State Free Energy Calculations. J. Chem. Theory Comput. 8, 3314\u20133321 (2012).","journal-title":"J. Chem. Theory Comput."},{"key":"62288_CR70","doi-asserted-by":"publisher","first-page":"e2412985","DOI":"10.1002\/advs.202412985","volume":"12","author":"X Wan","year":"2025","unstructured":"Wan, X. et al. Identification of a Novel Substrate for eEF2K and the AURKA-SOX8 as the Related Pathway in TNBC. Adv. Sci. 12, e2412985 (2025).","journal-title":"Adv. Sci."},{"key":"62288_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202207257","volume":"10","author":"T Jiang","year":"2023","unstructured":"Jiang, T. et al. Targeting lncRNA DDIT4-AS1 Sensitizes Triple Negative Breast Cancer to Chemotherapy via Suppressing of Autophagy. Adv. Sci. 10, e2207257 (2023).","journal-title":"Adv. Sci."},{"key":"62288_CR72","doi-asserted-by":"publisher","unstructured":"Gong R. et al. GPX4-AUTAC induces ferroptosis in breast cancer by promoting the selective autophagic degradation of GPX4 mediated by TRAF6-p62, Cell Death Differ. https:\/\/doi.org\/10.1038\/s41418-025-01528-1. Online ahead of print (2025).","DOI":"10.1038\/s41418-025-01528-1"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62288-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62288-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62288-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T12:20:30Z","timestamp":1757420430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62288-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["62288"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-62288-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7854"}}